Business Context and Reporting Period
Achieve Life Sciences, Inc. (ACHV) filed a Form 8-K on October 20, 2020, reporting the termination of a material definitive agreement. The company is incorporated in Delaware and operates from Vancouver, B.C., Canada.
Key Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The document solely addresses the termination of an equity offering agreement.
Material Changes
- Termination of Offering Agreement: The Company terminated its At The Market Offering Agreement dated June 7, 2019, with H.C. Wainwright & Co., LLC.
- Effective Date: The termination became effective at the close of business on October 20, 2020.
- Utilization: The Company did not sell any shares of Common Stock under the agreement prior to its termination. The agreement allowed for the sale of up to $6.0 million in aggregate offering price.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies beyond the specific event of the agreement termination.
Investor Verification Checklist
- Verify the Company's current capital raising strategy following the termination of the $6.0 million ATM facility.
- Confirm the Company's cash position and runway in subsequent filings (e.g., 10-Q or 10-K) given the lack of sales under the terminated agreement.
- Review the terms of the original June 7, 2019 agreement to ensure no termination fees or obligations remain.